Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2853
H.R.2853: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced April 26, 2021
- Latest Major Action April 27, 2021
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Version
- Introduced in House - April 26, 2021
Bill Summary
Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021 or the BLOCKING Act of 2021 This bill modifies provisions related to market exclusivity for a generic drug. Currently, the Food and Drug Administration (FDA) awards 180 days of exclusivity on the market to a first applicant to file a qualifying application for market approval of a generic drug. Generally, this exclusivity period begins upon a first...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| April 27, 2021 |
Referred to the Subcommittee on Health.
|
| April 26, 2021 |
Referred to the House Committee on Energy and Commerce.
|
| April 26, 2021 |
Introduced in the House by Kurt Schrader (D-Ore.) |